Literature DB >> 8534965

Malabsorption of food cobalamin.

R Carmel1.   

Abstract

Food-cobalamin malabsorption is marked by the inability to release cobalamin from food, which therefore cannot be taken up by intrinsic factor for absorption. The defect is not detectable by classical clinical tests like the Schilling test which are all based on the absorption of free, crystalline cobalamin. Tests of food-cobalamin absorption have been devised, the most popular ones using cobalamin bound to eggs or to chicken serum. The disparity between the abnormal results of these tests and the normal results with the Schilling test defines the disorder of food-cobalamin malabsorption. Release of cobalamin from food requires acid and pepsin, and most food-cobalamin malabsorptive states can be traced to gastric defects. However, other mechanisms may also play a role. The malabsorption is limited to food cobalamin and any free cobalamin, presumably including recycled biliary cobalamin, will be absorbed normally, which may explain its frequently insidious nature. The effect on cobalamin status covers a broad spectrum. At one extreme, some individuals, perhaps in the earliest stages, have normal cobalamin status, while at the other extreme may be found deficiency every bit as severe as in the most florid case of pernicious anaemia. Most often, however, the deficiency is mild, frequently marked by only a low serum cobalamin level, mild evidence of metabolic insufficiency and, sometimes, minimal clinical sequelae. Moreover, in some cases the gastric defect progresses and intrinsic factor secretion is affected, thus transforming into classical pernicious anaemia; this is not inevitable, however, and probably occurs in only a minority of patients. The course of food-cobalamin malabsorption is therefore a varied one. Nevertheless, it may be the most common cause of subtle or mild cobalamin deficiency and it is also sometimes associated with severe deficiency. Its identification and treatment need to be considered more widely in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8534965     DOI: 10.1016/s0950-3536(05)80224-0

Source DB:  PubMed          Journal:  Baillieres Clin Haematol        ISSN: 0950-3536


  21 in total

1.  How I treat cobalamin (vitamin B12) deficiency.

Authors:  Ralph Carmel
Journal:  Blood       Date:  2008-07-07       Impact factor: 22.113

Review 2.  Age-related lysosomal dysfunction: an unrecognized roadblock for cobalamin trafficking?

Authors:  Hua Zhao; Ulf T Brunk; Brett Garner
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

3.  Pernicious anemia: what are the actual diagnosis criteria?

Authors:  Daniel Cattan
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

4.  Production of ectopic gastric intrinsic factor in gastric mucosa of humans with chronic gastritis.

Authors:  J S Shao; R Carmel; D H Alpers
Journal:  Dig Dis Sci       Date:  2011-05-13       Impact factor: 3.199

5.  Hypersegmented neutrophils and oval macrocytes in the setting of B12 deficiency and pancytopaenia.

Authors:  Sean James Farrelly; Kieran Anthony O'Connor
Journal:  BMJ Case Rep       Date:  2017-08-17

Review 6.  Mandatory fortification of the food supply with cobalamin: an idea whose time has not yet come.

Authors:  Ralph Carmel
Journal:  J Inherit Metab Dis       Date:  2010-06-25       Impact factor: 4.982

7.  Effects of oral crystalline cyanocobalamin 1000 μg/d in the treatment of pernicious anemia: An open-label, prospective study in Ten Patients.

Authors:  Emmanuel Andrès; Noureddine Henoun Loukili; Esther Noel; Frédéric Maloisel; Stéphane Vinzio; Georges Kaltenbach; Florence Caro-Sampara; Jean-Frédéric Blicklé
Journal:  Curr Ther Res Clin Exp       Date:  2005-01

Review 8.  Vitamin B12 (cobalamin) deficiency in elderly patients.

Authors:  Emmanuel Andrès; Noureddine Henoun Loukili; Esther Noel; Georges Kaltenbach; Maher Ben Abdelgheni; Anne Elisabeth Perrin; Marie Noblet-Dick; Frédéric Maloisel; Jean-Louis Schlienger; Jean-Frédéric Blicklé
Journal:  CMAJ       Date:  2004-08-03       Impact factor: 8.262

Review 9.  Update on oral cyanocobalamin (vitamin B12) treatment in elderly patients.

Authors:  Emmanuel Andrès; Thomas Vogel; Laure Federici; Jacques Zimmer; Georges Kaltenbach
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Cobalamin deficiency in elderly patients: a personal view.

Authors:  Emmanuel Andrès; Thomas Vogel; Laure Federici; Jacques Zimmer; Ecaterina Ciobanu; Georges Kaltenbach
Journal:  Curr Gerontol Geriatr Res       Date:  2008-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.